Distinct expression and activity of GSK-3α and GSK-3β in prostate cancer-Reference-Cited by-同舟云学术

Distinct expression and activity of GSK-3α and GSK-3β in prostate cancer

Published:2012-05-22 Issue:6 Volume:131 Page:E872-E883
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Darrington R. Siobhan,Campa Victor M.,Walker Marjorie M.,Bengoa-Vergniory Nora,Gorrono-Etxebarria Irantzu,Uysal-Onganer Pinar,Kawano Yoshiaki,Waxman Jonathan,Kypta Robert M.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference49 articles.

1. GSK-3: functional insights from cell biology and animal models;Kaidanovich-Beilin;Front Mol Neurosci,2011

2. Growth control of multiple myeloma cells through inhibition of glycogen synthase kinase-3;Zhou;Leuk Lymphoma,2008

3. Glycogen synthase kinase-3β: a prognostic marker and a potential therapeutic target in human bladder cancer;Naito;Clin Cancer Res,2010

4. Potential therapeutic effect of glycogen synthase kinase 3β inhibition against human glioblastoma;Miyashita;Clin Cancer Res,2009

5. Glycogen synthase kinase-3 inhibition disrupts nuclear factor-κB activity in pancreatic cancer, but fails to sensitize to gemcitabine chemotherapy;Mamaghani;BMC Cancer,2009

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DVL/GSK3/ISL1 pathway signaling: unraveling the mechanism of SIRT3 in neurogenesis and AD therapy;Stem Cell Research & Therapy;2024-09-12

2. Beyond Expression: Role of Phosphorylated Residues of EZH2 in Lineage Plasticity in Prostate Cancer;Endocrinology;2023-01-30

3. Characterization of neuroendocrine regulation- and metabolism-associated molecular features and prognostic indicators with aid to clinical chemotherapy and immunotherapy of patients with pancreatic cancer;Frontiers in Endocrinology;2023-01-20

4. Re-Expression of ERα and AR in Receptor Negative Endocrine Cancers via GSK3 Inhibition;Frontiers in Oncology;2022-03-24

5. Glycogen synthase kinase GSK3α promotes tumorigenesis by activating HIF1/VEGFA signaling pathway in NSCLC tumor;Cell Communication and Signaling;2022-03-15